{
  "url": "https://openlegislation.uk/medicines-advisory-bodies-no-2-regulations-2005/schedule-3/paragraph-2",
  "json_url": "https://openlegislation.uk/medicines-advisory-bodies-no-2-regulations-2005/schedule-3/paragraph-2.json",
  "legislation": "uksi/2005/2754",
  "legislation_title": "The Medicines (Advisory Bodies) (No. 2) Regulations 2005",
  "legislation_url": "https://openlegislation.uk/medicines-advisory-bodies-no-2-regulations-2005",
  "path": "schedule/3/paragraph/2",
  "kind": "paragraph",
  "number": "2",
  "heading": null,
  "text": "In regulation 19 (authorization procedure for clinical trials involving medicinal products for gene therapy etc), in paragraph (10), in sub-paragraph (a), for “Committee on Safety of Medicines” substitute “Commission on Human Medicines established by section 2A of the Act”.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2005/2754/schedule/3/paragraph/2",
    "retrieved_at": "2026-10-29T04:49:26.804880+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}